Vor Biopharma Inc. VOR
19.19 USD +0.67 (+3.62%)
Regular-session close
19.40 +0.21 +1.09%
After hours · Nov 20, 4:39 PM ET
17.99 Day range 19.91
6.86 52-week range 25.10
- YTD
- +46.71%
- 1 year
- +179.74%
News
benzinga.com Buckle Posts Strong Q3 Results, Joins Evolent Health, Bending Spoons And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed as Nasdaq fell over 2%; Buckle surged 7.8% on strong results, while Evolent, Gap and others gained.benzinga.com Vor Bio Announces Final Two-Year Results From Phase 3 TELIGAN Trial Evaluating Telitacicept In Adults With Iga Nephropathy; TELIGAN Met Stage B Primary Endpoint Annualized eGFR slope of -0.6 vs. -5.7 mL/min/1.73 m²/year for placebo, a 5.1 mL/min/1.73 m²/year treatment difference (p<0.001)89% and 81% reductions in risk of confirmed ≥30% and ≥40% eGFR declines,
